Bioharvest Sciences (BHST) Cost of Revenue (2023 - 2025)

Bioharvest Sciences' Cost of Revenue history runs 3 years deep, the most recent figure standing at $3.8 million for Q4 2025.

• On a quarterly basis, Cost of Revenue rose 5.46% year-over-year to $3.8 million in Q4 2025; TTM through Dec 2025 was $14.0 million, a 19.59% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, up 19.59% from the prior year.
• Cost of Revenue climbed to $3.8 million in Q4 2025 per BHST's latest filing, from $3.5 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $3.8 million in Q4 2025 and bottomed at $1.6 million in Q2 2023.
• The 3-year median for Cost of Revenue is $2.9 million (2024), against an average of $2.9 million.
• Across the five-year window, Cost of Revenue surged 77.92% in 2024 and advanced 5.46% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $2.2 million in 2023, then soared by 63.54% to $3.6 million in 2024, then advanced by 5.46% to $3.8 million in 2025.
• Per Business Quant, the three latest BHST Cost of Revenue figures stand at $3.8 million (Q4 2025), $3.5 million (Q3 2025), and $3.4 million (Q2 2025).